Currently 1,200,000 people die every year from multidrug-resistant bacteria.
By 2050, these figures are expected to rise to 10,000,000 deaths a year.
It's up to us
With effective new treatments, millions of lives could be saved in the coming years.
To Discover and Develop
Without new antibiotics, the efficacy of cancer treatments, transplants, complex surgeries, and many other advances in modern medicine is at risk. The objective of AD-ES is to raise awareness and collaborate with policy makers and health authorities, in the need to promote the discovery of new therapeutic agents for the treatment of infections caused by resistant pathogens. AD-ES is also committed to communicating and raising awareness in society about the phenomenon of antimicrobial resistance and its consequences on global public health.